These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38521339)

  • 1. A combinatorial strategy for HRV 3C protease engineering to achieve the N-terminal free cleavage.
    Mei M; Fan X; Zhou Y; Zhang F; Zhang G; Yi L
    Int J Biol Macromol; 2024 Apr; 265(Pt 2):131066. PubMed ID: 38521339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative Analysis of the Substrate Specificity of Human Rhinovirus 3C Protease and Exploration of Its Substrate Recognition Mechanisms.
    Fan X; Li X; Zhou Y; Mei M; Liu P; Zhao J; Peng W; Jiang ZB; Yang S; Iverson BL; Zhang G; Yi L
    ACS Chem Biol; 2020 Jan; 15(1):63-73. PubMed ID: 31613083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights into cleavage specificity from the crystal structure of foot-and-mouth disease virus 3C protease complexed with a peptide substrate.
    Zunszain PA; Knox SR; Sweeney TR; Yang J; Roqué-Rosell N; Belsham GJ; Leatherbarrow RJ; Curry S
    J Mol Biol; 2010 Jan; 395(2):375-89. PubMed ID: 19883658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tripeptide aldehyde inhibitors of human rhinovirus 3C protease: design, synthesis, biological evaluation, and cocrystal structure solution of P1 glutamine isosteric replacements.
    Webber SE; Okano K; Little TL; Reich SH; Xin Y; Fuhrman SA; Matthews DA; Love RA; Hendrickson TF; Patick AK; Meador JW; Ferre RA; Brown EL; Ford CE; Binford SL; Worland ST
    J Med Chem; 1998 Jul; 41(15):2786-805. PubMed ID: 9667969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P1' specificity of the S219V/R203G mutant tobacco etch virus protease.
    Golda M; Hoffka G; Cherry S; Tropea JE; Lountos GT; Waugh DS; Wlodawer A; Tőzsér J; Mótyán JA
    Proteins; 2024 Sep; 92(9):1085-1096. PubMed ID: 38666764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The P1' specificity of tobacco etch virus protease.
    Kapust RB; Tözsér J; Copeland TD; Waugh DS
    Biochem Biophys Res Commun; 2002 Jun; 294(5):949-55. PubMed ID: 12074568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substrate requirements of human rhinovirus 3C protease for peptide cleavage in vitro.
    Cordingley MG; Callahan PL; Sardana VV; Garsky VM; Colonno RJ
    J Biol Chem; 1990 Jun; 265(16):9062-5. PubMed ID: 2160953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of lysine 60f to S1' specificity of thrombin.
    Rezaie AR; Olson ST
    Biochemistry; 1997 Feb; 36(5):1026-33. PubMed ID: 9033392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding the P1' specificity of the matrix metalloproteinases: effect of S1' pocket mutations in matrilysin and stromelysin-1.
    Welch AR; Holman CM; Huber M; Brenner MC; Browner MF; Van Wart HE
    Biochemistry; 1996 Aug; 35(31):10103-9. PubMed ID: 8756473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid peptide-based screening on the substrate specificity of severe acute respiratory syndrome (SARS) coronavirus 3C-like protease by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
    Chu LH; Choy WY; Tsai SN; Rao Z; Ngai SM
    Protein Sci; 2006 Apr; 15(4):699-709. PubMed ID: 16600962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of Self-Processing Activities and Substrate Specificities of Porcine Torovirus 3C-Like Protease.
    Xu S; Zhou J; Chen Y; Tong X; Wang Z; Guo J; Chen J; Fang L; Wang D; Xiao S
    J Virol; 2020 Sep; 94(20):. PubMed ID: 32727876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An engineered viral protease exhibiting substrate specificity for a polyglutamine stretch prevents polyglutamine-induced neuronal cell death.
    Sellamuthu S; Shin BH; Han HE; Park SM; Oh HJ; Rho SH; Lee YJ; Park WJ
    PLoS One; 2011; 6(7):e22554. PubMed ID: 21799895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 Protease Uses Bi-Specific S2/S2' Subsites to Optimize Cleavage of Two Classes of Target Sites.
    Potempa M; Lee SK; Kurt Yilmaz N; Nalivaika EA; Rogers A; Spielvogel E; Carter CW; Schiffer CA; Swanstrom R
    J Mol Biol; 2018 Dec; 430(24):5182-5195. PubMed ID: 30414407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombin specificity. Requirement for apolar amino acids adjacent to the thrombin cleavage site of polypeptide substrate.
    Chang JY
    Eur J Biochem; 1985 Sep; 151(2):217-24. PubMed ID: 2863141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineering the S1' subsite of trypsin: design of a protease which cleaves between dibasic residues.
    Kurth T; Grahn S; Thormann M; Ullmann D; Hofmann HJ; Jakubke HD; Hedstrom L
    Biochemistry; 1998 Aug; 37(33):11434-40. PubMed ID: 9708978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substrate specificity and novel selective inhibitors of TNF-alpha converting enzyme (TACE) from two-dimensional substrate mapping.
    Lambert MH; Blackburn RK; Seaton TD; Kassel DB; Kinder DS; Leesnitzer MA; Bickett DM; Warner JR; Andersen MW; Badiang JG; Cowan DJ; Gaul MD; Petrov KG; Rabinowitz MH; Wiethe RW; Becherer JD; McDougald DL; Musso DL; Andrews RC; Moss ML
    Comb Chem High Throughput Screen; 2005 Jun; 8(4):327-39. PubMed ID: 16101009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profiling Substrate Specificity of the SUMO Protease Ulp1 by the YESS-PSSC System to Advance the Conserved Mechanism for Substrate Cleavage.
    Zhang F; Zheng H; Xian Y; Song H; Wang S; Yun Y; Yi L; Zhang G
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3C-like protease of rabbit hemorrhagic disease virus: identification of cleavage sites in the ORF1 polyprotein and analysis of cleavage specificity.
    Wirblich C; Sibilia M; Boniotti MB; Rossi C; Thiel HJ; Meyers G
    J Virol; 1995 Nov; 69(11):7159-68. PubMed ID: 7474137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, and evaluation of nonpeptidic inhibitors of human rhinovirus 3C protease.
    Webber SE; Tikhe J; Worland ST; Fuhrman SA; Hendrickson TF; Matthews DA; Love RA; Patick AK; Meador JW; Ferre RA; Brown EL; DeLisle DM; Ford CE; Binford SL
    J Med Chem; 1996 Dec; 39(26):5072-82. PubMed ID: 8978838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NT*-HRV3CP: An optimized construct of human rhinovirus 14 3C protease for high-yield expression and fast affinity-tag cleavage.
    Abdelkader EH; Otting G
    J Biotechnol; 2021 Jan; 325():145-151. PubMed ID: 33166527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.